8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      NecroX-5 prevents hypoxia/reoxygenation injury by inhibiting the mitochondrial calcium uniporter.

      Cardiovascular Research
      Animals, Antioxidants, pharmacology, Calcium, metabolism, Calcium Channels, drug effects, Heart, physiology, Heterocyclic Compounds with 4 or More Rings, therapeutic use, Male, Membrane Potentials, Mitochondria, Heart, Myocardial Reperfusion Injury, prevention & control, Myocardium, Oxidative Stress, Oxygen Consumption, Rats, Rats, Sprague-Dawley, Reactive Oxygen Species, Sulfones

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Preservation of mitochondrial function is essential to limit myocardial damage in ischaemic heart disease. We examined the protective effects and mechanism of a new compound, NecroX-5, on rat heart mitochondria in a hypoxia/reoxygenation (HR) model. NecroX-5 reduced mitochondrial oxidative stress, prevented the collapse in mitochondrial membrane potential, improved mitochondrial oxygen consumption, and suppressed mitochondrial Ca(2+) overload during reoxygenation in an in vitro rat heart HR model. Furthermore, NecroX-5 reduced the ouabain- or histamine-induced increase in mitochondrial Ca(2+). These findings suggest that NecroX-5 may act as a mitochondrial Ca(2+) uniporter inhibitor to protect cardiac mitochondria against HR damage.

          Related collections

          Author and article information

          Comments

          Comment on this article